Provided by Tiger Trade Technology Pte. Ltd.

Dyne Therapeutics, Inc.

18.03
-1.1600-6.04%
Volume:2.33M
Turnover:42.47M
Market Cap:3.36B
PE:-5.38
High:19.00
Open:18.96
Low:17.93
Close:19.19
52wk High:27.31
52wk Low:11.92
Shares:186.58M
Float Shares:186.00M
Volume Ratio:0.60
T/O Rate:1.25%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.3486
EPS(LYR):-3.4740
ROE:-81.57%
ROA:-38.96%
PB:4.79
PE(LYR):-5.19

Loading ...

TD Cowen Initiates Dyne Therapeutics at Buy

MT Newswires Live
·
Jun 26

Joseph Thome Initiates Buy on Dyne Therapeutics, Citing Late-Stage Pipeline Strength and Multi-Billion-Dollar Peak Sales Potential

TIPRANKS
·
Jun 26

U.S. Research Roundup-american Tower, H.B. Fuller Company, TD Synnex

Reuters
·
Jun 26

Dyne Therapeutics (DYN) Adds Barry Greene And Expands Funding, Is The Stock Still A Bargain?

Simply Wall St.
·
Jun 25

Dyne Director Dirk Kersten Reports Disposal of Dyne Therapeutics Common Shares Worth $5.44 Million

Reuters
·
Jun 25

Dyne Therapeutics Names Barry Greene Independent Board Director

TIPRANKS
·
Jun 23

Dyne Therapeutics director Dirk Kersten disposes of 84,355 common shares worth $1.7 million

Reuters
·
Jun 23

Press Release: Dyne Therapeutics Appoints Barry Greene to Board of Directors

Dow Jones
·
Jun 23

Dyne Therapeutics grants new hires stock options for 126,000 shares, RSUs for 40,100 shares

Reuters
·
Jun 19

Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Jun 19

Dyne Therapeutics Shares Rise After Amendment to Debt Facility

Dow Jones
·
Jun 17

Dyne Therapeutics, - Adds up to $125 Mln in Additional Borrowing Capacity

THOMSON REUTERS
·
Jun 17

Press Release: Dyne Therapeutics Announces Expanded Debt Facility of Up To $400 Million with Hercules Capital, Inc.

Dow Jones
·
Jun 17

Insider Makes Bold New Move on Dyne Therapeutics Stock

TIPRANKS
·
Jun 10

Dyne Therapeutics director Brian S. Posner reports $33,880 common share purchase

Reuters
·
Jun 10

Dyne Therapeutics (DYN) Is Down 9.8% After Doubling Share Authorization Amid Key Rare Disease Milestones

Simply Wall St.
·
Jun 09

Dyne Therapeutics Expands Share Authorization After Stockholder Approvals

TIPRANKS
·
Jun 09

Dyne Therapeutics shareholders approved charter amendment raising authorized common shares to 400 million

Reuters
·
Jun 09

Dyne Therapeutics Insider Makes Bold New Move in Company Stock

TIPRANKS
·
Jun 06

Dyne Therapeutics director Brian S. Posner reports purchase of 2,500 common shares worth $43,700

Reuters
·
Jun 06